Rare diseases
Investigational molecules
Locations
Back to Norway123 clinical trials in Loerenskog, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)NorwayRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
NorwayStudy of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
NorwayBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
NorwayA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
NorwayA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
NorwayA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
NorwayA study testing duvakitug for patients with moderately to severely active ulcerative colitis
NorwayA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
NorwayStudy of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread
NorwayStudy of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
NorwayStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
NorwayThe busiest research cities in the country
What the registry says about research in the country
Research focusing on pulmonary diseases including trials for new treatments in idiopathic pulmonary fibrosis and COPD. Studies evaluating innovative therapies for chronic wet cough in children and investigating respiratory complications in systemic autoimmune conditions.
Advanced clinical research examining both medication efficacy and symptom management approaches.
Comprehensive studies on inflammatory bowel diseases, including trials for Ulcerative Colitis and Crohn's Disease. Research extends to liver conditions like Primary Sclerosing Cholangitis and colorectal cancer treatments.
Innovative approaches focusing on long-term disease management and diagnostic advancement.
Groundbreaking trials in hematological malignancies and solid tumors, including studies on chronic lymphocytic leukemia, lung cancer, and mesothelioma. Focus on combination therapies and targeted treatments.
Advanced therapeutic approaches combining immunotherapy with conventional treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
